These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11606148)

  • 1. Sustained-release sodium fluoride in the treatment of the elderly with established osteoporosis.
    Rubin CD; Pak CY; Adams-Huet B; Genant HK; Li J; Rao DS
    Arch Intern Med; 2001 Oct; 161(19):2325-33. PubMed ID: 11606148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of nonrandomized trials with slow-release sodium fluoride with a randomized placebo-controlled trial in postmenopausal osteoporosis.
    Pak CY; Adams-Huet B; Sakhaee K; Bell NH; Licata A; Johnston C; Rubin B; Bonnick S; Piziak V; Graham H; Ballard J; Berger R; Fears W; Breslau N; Rubin C
    J Bone Miner Res; 1996 Feb; 11(2):160-8. PubMed ID: 8822339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Slow-release sodium fluoride in the management of postmenopausal osteoporosis. A randomized controlled trial.
    Pak CY; Sakhaee K; Piziak V; Peterson RD; Breslau NA; Boyd P; Poindexter JR; Herzog J; Heard-Sakhaee A; Haynes S; Adams-Huet B; Reisch JS
    Ann Intern Med; 1994 Apr; 120(8):625-32. PubMed ID: 8135445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of sodium fluoride (60 mg) +/- estrogen in postmenopausal osteoporotic vertebral fractures: increased vertebral fractures and peripheral bone loss with sodium fluoride; concurrent estrogen prevents peripheral loss, but not vertebral fractures.
    Gutteridge DH; Stewart GO; Prince RL; Price RI; Retallack RW; Dhaliwal SS; Stuckey BG; Drury P; Jones CE; Faulkner DL; Kent GN; Bhagat CI; Nicholson GC; Jamrozik K
    Osteoporos Int; 2002; 13(2):158-70. PubMed ID: 11908491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of postmenopausal osteoporosis with slow-release sodium fluoride. Final report of a randomized controlled trial.
    Pak CY; Sakhaee K; Adams-Huet B; Piziak V; Peterson RD; Poindexter JR
    Ann Intern Med; 1995 Sep; 123(6):401-8. PubMed ID: 7639438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous ibandronate or sodium-fluoride--a 3.5 years study on bone density and fractures in Crohn's disease patients with osteoporosis.
    Klaus J; Reinshagen M; Herdt K; Adler G; von Boyen GB; von Tirpitz C
    J Gastrointestin Liver Dis; 2011 Jun; 20(2):141-8. PubMed ID: 21725510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.
    Harris ST; Watts NB; Genant HK; McKeever CD; Hangartner T; Keller M; Chesnut CH; Brown J; Eriksen EF; Hoseyni MS; Axelrod DW; Miller PD
    JAMA; 1999 Oct; 282(14):1344-52. PubMed ID: 10527181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of sodium monofluorophosphate plus calcium on vertebral fracture rate in postmenopausal women with moderate osteoporosis. A randomized, controlled trial.
    Reginster JY; Meurmans L; Zegels B; Rovati LC; Minne HW; Giacovelli G; Taquet AN; Setnikar I; Collette J; Gosset C
    Ann Intern Med; 1998 Jul; 129(1):1-8. PubMed ID: 9652994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intermittent therapy with a slow-release fluoride preparation.
    Pak CY; Sakhaee K; Zerwekh JE
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S149-55. PubMed ID: 2339625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.
    Ettinger B; Black DM; Mitlak BH; Knickerbocker RK; Nickelsen T; Genant HK; Christiansen C; Delmas PD; Zanchetta JR; Stakkestad J; Glüer CC; Krueger K; Cohen FJ; Eckert S; Ensrud KE; Avioli LV; Lips P; Cummings SR
    JAMA; 1999 Aug; 282(7):637-45. PubMed ID: 10517716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis.
    Kleerekoper M; Peterson EL; Nelson DA; Phillips E; Schork MA; Tilley BC; Parfitt AM
    Osteoporos Int; 1991 Jun; 1(3):155-61. PubMed ID: 1790403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial.
    Cummings SR; Black DM; Thompson DE; Applegate WB; Barrett-Connor E; Musliner TA; Palermo L; Prineas R; Rubin SM; Scott JC; Vogt T; Wallace R; Yates AJ; LaCroix AZ
    JAMA; 1998 Dec 23-30; 280(24):2077-82. PubMed ID: 9875874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial.
    Greenspan SL; Bone HG; Ettinger MP; Hanley DA; Lindsay R; Zanchetta JR; Blosch CM; Mathisen AL; Morris SA; Marriott TB;
    Ann Intern Med; 2007 Mar; 146(5):326-39. PubMed ID: 17339618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy.
    Meunier PJ; Sebert JL; Reginster JY; Briancon D; Appelboom T; Netter P; Loeb G; Rouillon A; Barry S; Evreux JC; Avouac B; Marchandise X
    Osteoporos Int; 1998; 8(1):4-12. PubMed ID: 9692071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis.
    Riggs BL; Hodgson SF; O'Fallon WM; Chao EY; Wahner HW; Muhs JM; Cedel SL; Melton LJ
    N Engl J Med; 1990 Mar; 322(12):802-9. PubMed ID: 2407957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of slow-release sodium fluoride on cancellous bone histology and connectivity in osteoporosis.
    Zerwekh JE; Hagler HK; Sakhaee K; Gottschalk F; Peterson RD; Pak CY
    Bone; 1994; 15(6):691-9. PubMed ID: 7873299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of intermittent slow-release sodium fluoride and continuous calcium citrate therapy on calcitropic hormones, biochemical markers of bone metabolism, and blood chemistry in postmenopausal osteoporosis.
    Zerwekh JE; Padalino P; Pak CY
    Calcif Tissue Int; 1997 Oct; 61(4):272-8. PubMed ID: 9312196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.
    Chesnut CH; Silverman S; Andriano K; Genant H; Gimona A; Harris S; Kiel D; LeBoff M; Maricic M; Miller P; Moniz C; Peacock M; Richardson P; Watts N; Baylink D
    Am J Med; 2000 Sep; 109(4):267-76. PubMed ID: 10996576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis.
    Meunier PJ; Roux C; Seeman E; Ortolani S; Badurski JE; Spector TD; Cannata J; Balogh A; Lemmel EM; Pors-Nielsen S; Rizzoli R; Genant HK; Reginster JY
    N Engl J Med; 2004 Jan; 350(5):459-68. PubMed ID: 14749454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bones and Crohn's: no benefit of adding sodium fluoride or ibandronate to calcium and vitamin D.
    Klaus J; Reinshagen M; Herdt K; Schröter C; Adler G; von Boyen GB; von Tirpitz C
    World J Gastroenterol; 2011 Jan; 17(3):334-42. PubMed ID: 21253392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.